![Cintia Piccina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cintia Piccina
Inga fler pågående positioner
Förmögenhet: 666 $ per 2026-05-31
Profil
Cintia Piccina formerly worked at Adaptimmune Therapeutics Plc, as Chief Commercial Officer from 2022 to 2023, Adaptimmune Therapeutics Plc, as Chief Commercial Officer, AlloVir, Inc., as Chief Commercial Officer from 2023 to 2024, 2seventy Bio, Inc., as SVP-Commercial Oncology & US General Manager from 2021 to 2022, and Novartis Pharmaceuticals Corp., as Vice President-Oncology from 1997 to 2020.
Dr. Piccina received her doctorate degree from the University of Sao Paulo and Masters Business Admin degree from Escola Superior de Propaganda e Marketing.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-04-11 | 666 438 ( 0,04 % ) | 666 $ | 2026-05-31 |
Tidigare kända positioner av Cintia Piccina
| Företag | Position | Slut |
|---|---|---|
| ALLOVIRPAR | Företagsledare/Principal | 2024-03-01 |
| ADAPTIMMUNE THERAPEUTICS PLC | Företagsledare/Principal | 2023-03-05 |
| 2SEVENTY BIO, INC. | Företagsledare/Principal | 2022-02-01 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Företagsledare/Principal | 2020-04-01 |
| ADAPTIMMUNE THERAPEUTICS PLC | Företagsledare/Principal | - |
Cintia Piccinas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
90
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escola Superior de Propaganda e Marketing
 Escola Superior de Propaganda e Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
